Axsome Therapeutics
AXSM
AXSM
341 hedge funds and large institutions have $3.95B invested in Axsome Therapeutics in 2025 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 151 increasing their positions, 89 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
341
Holders Change
-8
Holders Change %
-2.29%
% of All Funds
4.57%
Holding in Top 10
7
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-41.67%
% of All Funds
0.09%
New
54
Increased
151
Reduced
89
Closed
57
Calls
$66.7M
Puts
$69.3M
Net Calls
-$2.59M
Net Calls Change
-$27.1M
Top Buyers
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$83.7M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$60.6M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$41.7M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$38.7M |
| 5 |
BlackRock
New York
|
+$32.4M |
Top Sellers
| 1 |
RI
RTW Investments
New York
|
-$147M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$46.6M |
| 3 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$42.4M |
| 4 |
D.E. Shaw & Co
New York
|
-$36.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$29.8M |
